Since the late 1980s developing countries have come under considerable pressure to revise their intellectual property policies and practices. One area where pressures have been exceptionally controversial is in pharmaceuticals: historically, fearing the costs of providing private property rights over knowledge in this area, developing countries did not grant patents to drugs. Now they must do so.
view more